Blokpeyn – nonsteroid anti-inflammatory and antirheumatic drug.
toBLOKPEYN it is shown for short-term knocking over of a moderate and severe postoperative acute pain.
Treatment should be begun withonly in hospitals. The maximum duration of treatment – 2 days.
Structure
- active ingredient: ketorolac;
- 1 ml of solution the ketorolaka of a trometamol in terms of 100% contains substance of 30 mg;
- other components: sodium chloride, ethanol (96%), dinatrium edetat, sodium hydroxide, water for injections.
Contraindication
toBLOKPEYN it is contraindicated:
- to patients with hypersensitivity to a ketorolak of a trometamol, any of excipients of medicine or other NPVS in the anamnesis and also to patients with allergic reactions to acetylsalicylic acid or to other inhibitors of synthesis of prostaglandin (at such patients were observed). Such reactions included asthma, rhinitis, a Quincke's disease or a small tortoiseshell;
- to patients with asthma in the anamnesis;
- to children up to 16 years;
- to patients with an active round ulcer or gastrointestinal bleeding, ulcers or perforation in the anamnesis;
- as well as other NPVS, BLOKPEYN it is contraindicated to patients with a heavy heart, liver and renal failure; to patients with moderate or heavy renal failures (creatinine level in blood serum> 160 µmol/l) or to patients with risk of developing a renal failure owing to a hypovolemia or dehydration;
- during pregnancy, during the fights and childbirth or during feeding by a breast.
BLOKPEYN by
for an intramuscular or bolyusny injection. It is necessary to enter Bolyusny intravenous doses not less than 15 seconds. BLOKPEYN should not apply to epidural or spinal introduction.
Analgetic effect after intravenous and intramuscular administration comes equally approximately in 30 minutes, the maximum analgesic effect is reached within 1–2 hours. The average duration of an analgesia usually is 4 – 6 hours.
Dose of medicine should be selected and adjusted according to the degree of manifestation of pain and response of the patient.
Constant introduction of repeated daily doses in oil of a ketorolak has to last no more than 2 days as at prolonged use the risk of development of side reactions increases. Experience of prolonged use is limited as most of patients transferred to oral administration of medicine or after the period of intramuscular introduction the patients did not need the anesthetizing therapy any more.
Probability of side reactions can be minimized, applying the smallest effective dose during the shortest period necessary for control of symptoms.
Recommended initial medicament dose of BLOKPEYN makes 10 mg with the subsequent introduction on 10–30 mg each 4–6 hours if necessary. In the initial postoperative stage of BLOKPEYN if necessary it is possible to enter each 2 hours. It is necessary to appoint a minimal effective dose. The general daily dose should not exceed 90 mg for patients of young age, 60 mg for patients of advanced age, patients with a renal failure and patients with body weight <50 kg. The maximum duration of treatment should not exceed 2 days.
toFeature of application
toUse during pregnancy or feeding by a breast
toDue to the proved influence of NPVS on the cardiovascular system of a fruit (early closing of an arterial channel), a ketorolak trometamol it is contraindicated during pregnancy, fights or childbirth.
toIt was confirmed that ketorolak and its metabolites get to a fruit and milk of animals. Ketorolaka trometamol is found out in milk of the person in low concentration therefore BLOKPEYN is contraindicated to the nursing women.
Children Safety and efficiency of use of medicine at children are not established toby
. Thus, BLOKPEYN cannot be recommended for children 16 years are younger.
Ability to influence speed of response at control of motor transport or other mechanismsAt some patients at use of BLOKPEYN medicine can be observed by
dizziness, drowsiness, a disorder of vision, a headache, vertigo, insomnia or a depression. If these or other similar side reactions are observed, it is not necessary to steer vehicles or to work with exact mechanisms. Storage conditions
to Store
in original packing at a temperature not above 25 °C. to Store
out of children's reach.
Characteristics | |
Active ingredients | Ketorolak |
Amount of active ingredient | 30 mg/ml |
Applicant | Lekkhim |
Code of automatic telephone exchange | M01AB15 Ketorolak |
Interaction with food | It doesn't matter |
Light sensitivity | Not sensitive |
Market status | Generic-generic |
Origin | Chemical |
Prescription status | According to the prescription |
Primary packing | ampoule |
Producer | AT LEKHIM-HARKOV |
Quantity in packing | 10 ampoules |
Release form | solution for injections |
Route of administration | Intramuscular |
Sign | Import |
Storage temperature | from 5 °C to 25 °C |
Trade name | Ketorolak |
Blokpeyn solution for infection. 30mg/ml amp. 1 ml No. 10
- Product Code: 179797
- In Stock
- Ready to ship
-
$29.94